How to Buy Editas Medicine Stock
Editas Medicine Inc
Editas Medicine, Inc. , a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases.
Editas Medicine stock last closed at $1.33, up 3.91% from the previous day, and has decreased 76.25% in one year. It has overperformed other stocks in the Biotechnology industry by 0.01 percentage points. Editas Medicine stock is currently +46.15% from its 52-week low of $0.91, and -80.12% from its 52-week high of $6.69.
There are currently 82.98M EDIT shares outstanding. The market value of EDIT is $110.36M. In the past 24 hours, 1.77M EDIT shares were traded.
How to Buy Editas Medicine Stock
Wondering how to invest in Editas Medicine stock? Here's how.
- Figure out where to buy Editas Medicine stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you decide where to buy Editas Medicine stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Choose your method of payment and add your details.
- Research Editas Medicine stock: The Editas Medicine ticker symbol is EDIT. Is Editas Medicine stock a good investment? Should you buy shares of EDIT? How do EDIT's underlying business fundamentals look? Do top analysts think Editas Medicine is a good buy? Why has EDIT's stock price moved recently? (Hint: Our stock market analysis website can help you decide if EDIT is a good stock to buy).
- Execute your EDIT trade: Decide if you will purchase EDIT shares at the current market price or use a limit order to purchase EDIT shares at a given price.
- Get notifications regarding your EDIT investment: Create a watchlist to keep tabs on your position in Editas Medicine shares.
Step 1: Figure out where to buy Editas Medicine stock
You will need a brokerage account to access the NASDAQ market and buy EDIT stock.
Our favorite brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Tech to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you need to fill out some personal details so you can invest in EDIT today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start a new trading account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have created your account on investing apps, you need to deposit funds:
Watch the tutorial below for more details depositing funds into your new brokerage account.
Step 4: Research Editas Medicine stock
After you have chosen the best place to buy Editas Medicine stock, it's crucial to analyze their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
Editas Medicine Numbers
Fundamentals of EDIT
WallStreetZen was designed to help everyday investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on EDIT's stock page.
How is EDIT stock valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge EDIT's fair value.
Using relative valuations measures:
- EDIT may be undervalued based on its P/B ratio of 0.82x, relative to Biotechnology industry P/B ratio of 4.04x
You can access more valuation research on EDIT's stock here.
EDIT Financial Health Summary
Positive Financial Indicators:
- EDIT has cash burn of 219110000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the EDIT balance sheet.
- There are more short-term assets than short-term liabilities on the EDIT balance sheet.
Negative Financial Indicators:
- EDIT profit margin has gone down from -196.1% to -733.7% in the past year.
- Total EDIT debt is higher than 5 years ago, relative to shareholder equity.
- EDIT has $269.91M in cash and short term investments. This is not enough to cover its annual cash burn of $219.11M.
- EDIT has a relatively high debt to equity ratio of 1.54.
Do Wall Street analysts think it's a good time to buy Editas Medicine stock
Out of 8 Wall Street analysts who give ratings on EDIT, the consensus analyst rating on Editas Medicine is a Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Latest EDIT Analyst Recommendations
Yanan Zhu, a bottom 9% analyst from Wells Fargo downgrades EDIT to a hold rating and lowers their EDIT price target from $7.00 to $4.00, on Dec 11, 2024.
Geulah Livshits, a bottom 10% analyst from Chardan Capital maintains EDIT with a strong buy rating and maintains their EDIT price target from $12.00 to $12.00, on Nov 5, 2024.
Joon Lee, a top 2% analyst from Truist Securities maintains EDIT with a strong buy rating and lowers their EDIT price target from $12.00 to $8.00, on Nov 5, 2024.
You can dive deeper into what analysts are projecting on the Editas Medicine stock forecast page.
EDIT Technical Indicators
Is EDIT Making Money?
Last year, EDIT revenue was $32.31M. During the last five year, EDIT's revenue has grown by 9.5% per year. This was slower than the Biotechnology industry average of 44.31%.
Dig into EDIT's earnings and revenue performance here.
What are EDIT insiders up to?
Over the past year, executives and large shareholders at EDIT have sold more shares than they have bought.
Linda Burkly, EVP CHIEF SCIENTIFIC OFFICER of EDIT, was the latest EDIT insider to sell. They sold $4,946.50 worth of EDIT stock on Mar 4, 2025.
Research more about who owns EDIT shares here.
Does EDIT stock generate passive income?
No, Editas Medicine doesn't provide an income stream by paying out dividends.
What do other investors have to say about EDIT?
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your EDIT trade
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular price limit, use a limit order.
Press the Open button and your broker will execute your order.
If you require more help investing in stocks on eToro, watch the helpful video below:
Step 6: Get notifications regarding your EDIT investment
Now that you own some EDIT shares, you'll want to stay up-to-date on your new company.
Add EDIT to a watchlist to get the latest updates about your EDIT stock.
EDIT Feed
How to Buy Stock in Editas Medicine
To summarize, here are the 6 steps to buy stock in Editas Medicine:
- Figure out where to buy Editas Medicine stock
- Sign up for your brokerage account
- Fund your brokerage account
- Research Editas Medicine stock
- Execute your EDIT trade
- Get notifications regarding your EDIT investment
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Editas Medicine, click below.
More Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.